Healthcare M&A » By The Online Investor Staff, updated Sat., Aug. 17, 11:47 AM
Recent mergers and acquisitions in the Healthcare M&A category.
| This Slide: #100 of 100 |
Slide #100. Novartis — CoStim Pharmaceuticals, Inc.
Acquirer:
Novartis (NYSE:NVS)
Acquiree:
CoStim Pharmaceuticals, Inc.
Details:
MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. ("CoStim") has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.
Novartis is a multinational healthcare group based in Switzerland. Co. provides healthcare solutions that address the evolving needs of patients and societies worldwide. Co.'s broad portfolio includes innovative medicines, eye care products and cost-saving generic pharmaceuticals. Co.'s operations are organized along three operating divisions: Innovative Medicines Division; Sandoz Division; and Alcon Division. Co.'s operations are supported by the Novartis Institutes for BioMedical Research and Novartis Business Services.
Open the NVS Page at The Online Investor »
|
|||||||||||||||||||||
Open the NVS Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.50 out of 4) 62nd percentile
(ranked higher than approx. 62% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
